NovoCure Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Lyell and Accuray.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Accuray Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions. | ||
Founding Date | Founding Date 2000 | Founding Date 2018 | Founding Date 1990 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Madison, US HQ Chengdu, CN Kowloon, HK Tokyo, JP Morges, CH Santa Clara, US Sunnyvale, US | |
Employees | Employees 1,488 | Employees 188 | Employees 9874% decrease |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 243.3 m | Valuation ($) 186.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $458.5m (FY, 2025) |
Cost of goods | Cost of goods $166.9m (FY, 2025) | Cost of goods N/A | Cost of goods $311.5m (FY, 2025) |
Gross profit | Gross profit $488.5m (FY, 2025) | Gross profit N/A | Gross profit $147m (FY, 2025) |
Net income | Net income ($136.2m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income ($1.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyAccuray
HQ
Madison, US
Employees
987↓ 4% decrease
Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions.
View company